ProfileGDS5678 / 1458189_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 58% 58% 58% 56% 58% 62% 61% 58% 58% 57% 58% 58% 58% 58% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5266658
GSM967853U87-EV human glioblastoma xenograft - Control 23.5023658
GSM967854U87-EV human glioblastoma xenograft - Control 33.5037958
GSM967855U87-EV human glioblastoma xenograft - Control 43.3602356
GSM967856U87-EV human glioblastoma xenograft - Control 53.4692458
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.8092462
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.7074661
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4817258
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4669658
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4365257
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.5086458
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4831258
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4964958
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4913558